1. Home
  2. REAX vs VRXA Comparison

REAX vs VRXA Comparison

Compare REAX & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$1.99

Market Cap

435.9M

Sector

N/A

ML Signal

HOLD

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$2.06

Market Cap

390.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REAX
VRXA
Founded
2018
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.9M
390.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
REAX
VRXA
Price
$1.99
$2.06
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$5.49
N/A
AVG Volume (30 Days)
4.4M
1.2M
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.04
N/A
Revenue Next Year
$15.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$1.70
52 Week High
$5.41
$4.50

Technical Indicators

Market Signals
Indicator
REAX
VRXA
Relative Strength Index (RSI) 49.74 29.68
Support Level $1.92 $1.94
Resistance Level $2.30 $3.49
Average True Range (ATR) 0.16 0.38
MACD -0.01 0.04
Stochastic Oscillator 38.91 21.79

Price Performance

Historical Comparison
REAX
VRXA

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: